HomeCompareHRDIL vs MRK

HRDIL vs MRK: Dividend Comparison 2026

HRDIL yields 1000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRDIL wins by $4.7683925249533696e+36M in total portfolio value
10 years
HRDIL
HRDIL
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full HRDIL calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HRDIL vs MRK

📍 HRDIL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRDILMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRDIL + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRDIL pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRDIL
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HRDIL beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRDIL + MRK for your $10,000?

HRDIL: 50%MRK: 50%
100% MRK50/50100% HRDIL
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HRDIL
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRDIL buys
0
MRK buys
0
No recent congressional trades found for HRDIL or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRDILMRK
Forward yield1000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.7683925249533696e+36M$56.8K
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$4.7683311610149396e+36M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HRDIL vs MRK ($10,000, DRIP)

YearHRDIL PortfolioHRDIL Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,206$366.19+$100.00MHRDIL
2$934,786,450,701$934,679,439,252.34$12,650$502.35+$934786.44MHRDIL
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,407$694.19+$8165787108.56MHRDIL
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$16,585$967.82+$66665884190957.63MHRDIL
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$19,342$1,363.89+$508662171058048128.00MHRDIL
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$22,913$1,947.19+$3.62723524842849e+21MHRDIL
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$27,662$2,823.89+$2.417368115915061e+25MHRDIL
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$34,159$4,173.35+$1.5056740286145463e+29MHRDIL
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$43,337$6,308.80+$8.764771002818475e+32MHRDIL
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$56,776$9,798.13+$4.7683925249533696e+36MHRDIL

HRDIL vs MRK: Complete Analysis 2026

HRDILStock

Here Media Inc. offers original programming content tailored for the lesbian, gay, bisexual, and transgender (LGBT) community on a subscription basis. The company publishes magazines and books, as well as operates companion Websites targeting the LGBT community. Its products include the magazines Out, The Advocate, and HIVPlus, as well as books published by Alyson Books, which are distributed through traditional newsstands, other retail outlets, and by subscriptions of print and digital editions of the magazines. It also operates PlanetOut, an online media company serving the LGBT community through its website Gay.com, a social networking Website; and a companion Website, heretv.com that features original shows, podcasts, news, and other entertainment, as well as a library of LGBT-themed streaming video. In addition, the company provides subscription video-on-demand and/or regularly scheduled television channel services through cable, satellite, and fiber-optic television providers serving domestic television households in the United States; and syndicates free-to-the-user content to Websites, including msn.com and aol.com. It serves customers through cable television, direct-to-home satellite television, fiber-optic television, and the Internet under the brand name "here!". The company is was founded in 2009 and is headquartered in Los Angeles, California.

Full HRDIL Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HRDIL vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRDIL vs SCHDHRDIL vs JEPIHRDIL vs OHRDIL vs KOHRDIL vs MAINHRDIL vs JNJHRDIL vs ABBVHRDIL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.